Cure4Cancer

The fight against #cancer requires global solutions. Asia Society Policy Institute and Cure4Cancer’s latest report showcases the U.S.-#Australia Cancer Alliance as a blueprint for addressing disparities in cancer care, from clinical trial access to equitable precision oncology. Drawing from the strength of this partnership, this report calls for the simultaneous expansion of multilateral collaboration across the Asia-Pacific, a region that represents the world’s largest and fastest-growing economy, and where cancer care disparities are vast. Read the full report: https://lnkd.in/gSy2iB6F We gratefully acknowledge our partners and supporters in this initiative, including Memorial Sloan Kettering Cancer Center, Chinese Thoracic Oncology Group (CTONG), BloombergNEF, Forbes China 福布斯中国, Thoracic Oncology Group of Australasia, AstraZeneca, Amgen, BeiGene, and Boehringer Ingelheim. #Cure4Cancer #healthcare #globalhealth #cancerresearch #australia #asiapacific #asia #health #cancer #policy

Cancer remains one of the most pressing global health challenges, claiming 10 million lives each year and straining #healthcare systems. Asia Society Policy Institute and Cure4Cancer present Advancing Global Health Equity: Expanding the U.S.-Australia Cancer Alliance Toward an Asia-Pacific Collaborative to Save Millions of Lives. As the second installment of the Advancing Global Health Equity series, the report dives into the U.S.-Australia alliance and highlights how international collaboration—through precision oncology, clinical trials, and regulatory harmonization—can save millions of lives and reduce disparities in cancer care across the Asia-Pacific. Drawing from the strength of this partnership, this report calls for the simultaneous expansion of multilateral collaboration across the #AsiaPacific, a region that represents the world’s largest and fastest growing economy, and where #cancer care disparities are vast. We gratefully acknowledge our partners and supporters in this initiative, including Memorial Sloan Kettering Cancer Center, Chinese Thoracic Oncology Group (CTONG), BloombergNEF, Forbes China 福布斯中国, Thoracic Oncology Group of Australasia, AstraZeneca, Amgen, BeiGene and Boehringer Ingelheim. Read the full report and visit us at:?https://lnkd.in/gSy2iB6F

Honored to be one of the MSK Global Research Program delegates at the first Memorial Sloan Kettering Cancer Center and Hospital Sírio-Libanês R&D Symposium and the Bloomberg New Economy at B20 in S?o Paulo this week. As a Colombian with family members and friends who have faced not only cancer but also significant barriers to accessing optimal cancer care, my mission is to expand access to clinical trials in Latin America and establish a global model of collaboration. Together with my colleagues Bob Li, Pedram Razavi, Kaylie Johnson, MPH and team, and Hospital Sírio-Libanês as a regional leader and the involvement of key stakeholders from both the public and private sectors, I am optimistic about advancing the Cure4Cancer movement and achieving lasting impact in cancer care worldwide. #clinicaltrials #collaboration #cancercare #healthequity

The Bloomberg B20 event in Sao Paulo, Brazil was a milestone for our #Cure4Cancer global movement. Multiple leaders from Memorial Sloan Kettering Cancer Center, Hospital Sírio-Libanês, Dasa, Amgen, and public-private sectors in Latin America convened at the Bloomberg New Economy International Cancer Coalition roundtable, and converged on a shared strategy to advance global health equity in access to clinical trials and precision oncology. The future of oncology is no longer about ivory tower cancer centers, but cancer networks that may serve the 95% of patients in diverse global communities who miss out on clinical trials. Hence we decided to establish a multi-stakeholder Latin America Task Force to advance global health equity via a hub-and-spoke network model in this important region. Global is local, and in this post-pandemic era of technological transformation, we will cure cancer through collaboration and innovation. #cancer #oncology #clinicaltrials #international #collaboration #technology #healthequity

Honored to be one of the MSK Global Research Program delegates at the first Memorial Sloan Kettering Cancer Center and Hospital Sírio-Libanês R&D Symposium and the Bloomberg New Economy at B20 in S?o Paulo this week. As a Colombian with family members and friends who have faced not only cancer but also significant barriers to accessing optimal cancer care, my mission is to expand access to clinical trials in Latin America and establish a global model of collaboration. Together with my colleagues Bob Li, Pedram Razavi, Kaylie Johnson, MPH and team, and Hospital Sírio-Libanês as a regional leader and the involvement of key stakeholders from both the public and private sectors, I am optimistic about advancing the Cure4Cancer movement and achieving lasting impact in cancer care worldwide. #clinicaltrials #collaboration #cancercare #healthequity

Having just returned from Brazil this morning, it was a great honor for me and the Memorial Sloan Kettering Cancer Center Global Research Program delegates to be graciously hosted in Sao Paulo by the Hospital Sírio-Libanês leadership team for the HSL-MSK Research Symposium. This was an exciting milestone for our decades long partnership in education and training, as we expand the collaboration to include an international R&D dimension. Many clinical trials and biomarker development studies will advance as a result of this mission-driven international collaboration, to help patients in diverse global communities fight cancer. This is not just for patients in New York and Sao Paulo, but it is part of a larger global movement to accelerate the #Cure4Cancer for all patients worldwide. #cancer #oncology #clinicaltrials #international #collaboration #technology #biomarker #healthequity

Felicitaciones a Diego Carrillo y Héctor Galindo por la excelente organización de este Simposio con el apoyo de la Fundación Chilesincancer. Hubo grandes invitados nacionales e internacionales entre los que destaco a Bob Li del Memorial Sloan Kettering Cancer Center quien presentó acerca de la iniciativa?#Cure4Cancer que busca impulsar el desarrollo de estudios clínicos a nivel mundial para que así veamos la cura del cáncer en los próximos a?os. #cancer #clinicaltrials #precisiononcology #collaboration

Proud that our Cancer Discovery publication was recognized by Forbes, for advancing global health equity in oncology clinical trials. To achieve the #Cure4Cancer (eliminating cancer as a cause of death) in this lifetime, we must expand access to the 95% of patients who miss out on clinical trials and precision oncology. This dream can only be realized through multi-stakeholder collaboration, powered by technology innovation to enable global ecosystem transformation. Everyone has a role to play in our shared mission to defeat this common enemy of humanity, toward a shared future of a world marked by collaboration, not division and conflict. https://lnkd.in/eDE28d4A (download the Cancer Discovery publication) #cancer #oncology #clinicaltrials #precisiononcology #international #collaboration #technology Memorial Sloan Kettering Cancer Center Bloomberg New Economy Asia Society

At the conclusion of United Nations General Assembly 79th Session, I enjoyed a panel discussion with Dr. Darryl Sleep, MD (MBBCh, FCS(SA)) at Amgen, Dr. Nwamaka Lasebikan at Nigerian Institute for Cancer Research and Treatment (NICRAT), as hosted by Dr. Mayesha A. at Foreign Policy. We discussed the collaboration with Isabel Mestres and her team at City Cancer Challenge in building capacity in low- and middle- income countries (LMICs). Check out our concurrent publication in Cancer Discovery by Memorial Sloan Kettering Cancer Center, City Cancer Challenge, Amgen and many other public-private sector leaders worldwide, which contains our vision and the blueprint for global ecosystem transformation to accelerate the #Cure4Cancer. https://lnkd.in/eDE28d4A (Cancer Discovery publication) https://lnkd.in/eYnGET6M (Foreign Policy @UNGA79 video) #cancer #oncology #clinicaltrials #international #collaboration #LMIC #precisiononcology

On this #WorldCancerResearchDay, Asia Society's Cure4Cancer in collaboration with the Bloomberg New Economy International Cancer Coalition, Memorial Sloan Kettering Cancer Center, and McKinsey Cancer Center, unveils a pivotal new study that highlights a stark reality: fewer than 5% of eligible patients globally are participating in oncology clinical trials, despite an astounding $80 billion in biopharmaceutical R&D investment. ? The report sheds light on key barriers—across patient, clinician, and regulatory levels—that are preventing broader participation in trials, which are critical to advancing cancer treatments and care. Cure4Cancer is a global movement launched in 2018 by the Asia Society, Memorial Sloan Kettering Cancer Center (MSK),?and the Chinese Thoracic Oncology Group (CTONG), joined by Bloomberg New Economy Forum, Forbes China, Thoracic Oncology Group of Australasia (TOGA), Hospital Sirio-Libanes, and KRAS Kickers and others over the years, with a mission to accelerate the development of cancer cures and prevention through increased public awareness, international cooperation, and regulatory harmonization on patient-centric international clinical trials. Read the full study and learn more about how these strategies can shape the future of cancer care here: https://lnkd.in/es3Cjgnr #Cure4Cancer #CancerResearch #oncology #clinicaltrials